Biphasic effect of bradykinin on rabbit afferent arterioles

Hypertension

Volumn 32, Issue 2, 1998, Pages 287-292

  Yu, Hong ^a   Carretero, Oscar A ^a   Juncos, Luis A ^a   Garvin, Jeffrey L ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Nitric oxide; Prostaglandins; Receptors; Renal blood flow; Thromboxane

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; BRADYKININ; BRADYKININ[1-8]; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE;

ANIMAL TISSUE; ARTERIOLE; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; KALLIKREIN KININ SYSTEM; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT;

EID: 0031815832     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.2.287     Document Type: Article

References (43)

1. Barraclough MA, Mills IH. Effect of bradykinin on renal function. Clin Sci. 1965;28:69-74.
2. Carretero OA, Scicli AG. The renal kallikrein-kinin system. Am J Physiol. 1980;238:F247-F255.
3. Flamenbaum W, Gagnon J, Ramwell P. Bradykinin-induced renal hemodynamic alterations: renin and prostaglandin relationships. Am J Physiol. 1979;237:F433-F440.
4. Willis LR. Effect of bradykinin on the renal medullary osmotic gradient in water diuresis. Eur J Pharmatol. 1977;45:173-183.
5. Willis LR, Ludens JH, Hook JB, Williamson HE. Mechanism of natriuretic action of bradykinin. Am J Physiol. 1969;217:1-5.
6. Carretero OA, Scicli AG. The renal kallikrein-kinin system in human and in experimental hypertension. Klin Wochenschr. 1978;56(suppl 1):113-125.
7. Levinsky NG. The renal kallikrein-kinin system. Circ Res. 1979;44: 441-451.
8. Mills IH. Kallikrein, kininogen and kinins in control of blood pressure. Nephron. 1979;23:61-71.
9. Mair M, Zhegu Z, Binder BR. Hemodynamics of the isolated perfused rat kidney in the absence and presence of kallikrein substrate. Adv Exp Med Biol. 1986;198:173-180.
10. Rabito SF, Amin V, Scicli AG, Carretero OA. Glandular kallikrein in plasma and urine: evaluation of a direct RIA for its determination. Adv Exp Med Biol. 1979;120A:127-142.
11. Rabito SF, Scicli AG, Carretero OA. Immunoreactive glandular kallikrein in plasma. In: Gross F, Vogel G. eds. Enzymatic Release of Vasoactive Peptides. New York, NY: Raven Press; 1980:247-256.
12. Lortie M, Regoli D, Rhaleb N-E, Plante GE. The role of B1- and B2-kinin receptors in the renal tubular and hemodynamic response to bradykinin. Am J Physiol. 1992:262:R72-R76.
13. Lahera V, Salom MG, Fiksen-Olsen MJ, Romero JC. Mediatory role of endothelium-derived nitric oxide in renal vasodilatory and excretory effects of bradykinin. Am J Hypertens. 1991;4:260-262.
14. Quilley J, Fulton D, McGiff JC. The position of NO among endogenous vasodilators. Pol J Pharmacol. 1994;46:523-530.
15. Shayman JA, Hruska KA, Morrison AR. Bradykinin stimulates increased intracellular calcium in papillary collecting tubules of the rabbit. Biochem Biophys Res Commun. 1986;134:299-304.
16. Smits GJ, McGraw DE, Trapani AJ. Interaction of ANP and bradykinin during endopeptidase 24.11 inhibition: renal effects. Am J Physiol. 1990; 258:F1417-F1424.
17. Hajj-ali AF, Zimmerman BG. Kinin contribution to renal vasodilator effect of captopril in rabbit. Hypertension. 1991;17:504-509.
18. Tost H, Kóvér G, Szemerédi K. Study of the indomethacin and bradykinin antagonism in anaesthetized dogs. Acta Physiol Acad Sci Hung. 1982;59: 131-139.
19. Yun JCH, Gill JR Jr, Bartter FC, Kelly GD, Keiser HR. Effect of bradykinin on renal function in dogs treated with indomethacin or propranolol. Renal Physiol. 1982;5:31-43.
20. Edwards RM. Response of isolated renal arterioles to acetylcholine. dopamine, and bradykinin. Am J Physiol. 1985;248:F183-F189.
21. Carbonell LF, Carretero OA, Madeddu P, Scicli AG. Effects of a kinin antagonist on mean blood pressure. Hypertension. 1988;11(suppl I):I-84-I-88.
22. Carbonell LF, Carretero OA, Stewart JM, Scicli AG. Effect of a kinin antagonist on the acute antihypertensive activity of enalaprilat in severe hypertension. Hypertension. 1988;11:239-243.
23. Carretero OA, Scicli AG. Local hormonal factors (intracrine, autocrine, and paracrine) in hypertension. Hypertension. 1991;18(suppl I):I-58-I-69.
24. Genden EM, Molineaux CJ. Inhibition of endopeptidase-24.15 decreases blood pressure in normotensive rats. Hypertension. 1991;18:360-365.
25. Zimmerman BG, Raich PC, Vavrek RJ, Stewart JM. Bradykinin contribution to renal blood flow effect of angiotensin-converting enzyme inhibitor in the conscious sodium-restricted dog. Circ Res. 1990;66: 234-240.
26. 2 and nitric oxide. Hypertension 1997;29:757-762.
27. Itoh S, Carretero OA, Murray RD. Renin release from isolated afferent arterioles. Kidney Int. 1985;27:762-767.
28. Osgood RW, Patton M, Henley MJ, Venkatachalam M, Reineck J, Stein JH. In vitro perfusion of the isolated dog glomerulus. Am J Physiol. 1983;244:F349-F354.
29. Marshall JJ, Kontos HA. Endothelium-derived relaxing factors: a perspective from in vivo data. Hypertension. 1990;16:371-386.
30. Wilkes BM, Mento PF. Bradykinin-induced vasoconstriction and thromboxane release in perfused human placenta. Am J Physiol. 1988; 254:E681-E686.
31. Campbell DJ, Kladis A, Duncan A-M. Bradykinin peptides in kidney, blood, and other tissues of the rat. Hypertension. 1993;21:155-165.
32. Hulthén UL, Borge T. Determination of bradykinin in blood by a sensitive radioimmunoassay. Scand J Clin Lab Invest. 1976;36:833-839.
33. Ichikawa I, Harris RC. Angiotensin actions in the kidney: renewed insight into the old hormone. Kidney Int. 1991;40:583-596.
34. Schnermann J, Briggs JP. Function of the juxtaglomerular apparatus: control of glomerular hemodynamics and renin secretion. In: Seldin DW, Giebisch G. eds. The Kidney: Physiology and Pathology. 2nd ed. New York, NY: Raven Press; 1992:1249-1289.
35. 1-kinin receptors. Eur J Pharmacol. 1986;130:177-185.
36. Juncos LA, Ganin J, Carretero OA, Ito S. Flow modulates myogenic responses in isolated microperfused rabbit afferent arterioles via endothelium-derived nitric oxide. J Clin Invest. 1995;95:2741-2748.
37. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev. 1980;32:1-46.
38. Regoli D, Barabe J, Park WK. Receptors for bradykinin in rabbit aortae. Can J Physiol. 1977;55:855-867.
39. Regoli D, Jukic D, Gobell F, Rhaleb N-E. Receptor for bradykinin and related kinin: a critical analysis. Can J Physiol Pharmacol. 1993;71: 556-567.
40. Kachur JF, Allbee W, Danho W, Gaginella TS. Bradykinin receptors: functional similarities in guinea pig gut muscle and mucosa. Regul Pept. 1987;17:63-69.
41. Manning DC, Snyder SH, Kachur JF, Miller RJ, Field M. Bradykinin receptor-mediated chloride secretion in intestinal function. Nature. 1982; 299:256-259.
42. Figueroa CD, Gonzalez CB, Grigoriev S, Abd Alla S, Haasemann M, Jarnagin K, Müller-Esterl W. Probing for the bradykinin B2 receptor in the rat kidney by anti-peptide and anti-ligand antibodies. J Histochem Cytochem. 1995;43:137-148.
43. McGiff JC. Interactions of prostaglandins with the kallikrein-kinin and renin-angiotensin systems. Clin Sci. 1980;59:105s-116s.